Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 395501Generated: October 29, 2026

5-Chloromethyl-2-(3,4,5-trimethoxyphenyl)pyridine → 4-[N-(indan-5-yl)-N-[[2-(3,4,5-trimethoxyphenyl)pyridin-5-yl]methyl]amino]-1-[[2-(3,4,5-trimethoxyphenyl)pyridin-5-yl]methyl]piperidine trihydrochloride

https://huagongshe.com/reaction/395501

Reaction equation

Participants

RoleNameHCIDCharge
Reactant5-Chloromethyl-2-(3,4,5-trimethoxyphenyl)pyridineHCID 12043486—
Reactant4-(5-Indanylamino)-1-[[2-(3,4,5-trimethoxyphenyl)pyridin-4-yl]methyl]piperidineHCID 22557857—
Product4-[N-(indan-5-yl)-N-[[2-(3,4,5-trimethoxyphenyl)pyridin-5-yl]methyl]amino]-1-[[2-(3,4,5-trimethoxyphenyl)pyridin-5-yl]methyl]piperidine trihydrochlorideHCID 22557814—

Reaction Steps

4-(5-Indanylamino)-1-[[2-(3,4,5-trimethoxyphenyl)pyridin-4-yl]methyl]piperidine (143 mg) and 5-chloromethyl-2-(3,4,5-trimethoxyphenyl)pyridine (114 mg) were condensed in the same manner as described in Example 9. The title compound was obtained as yellow powder after converting a free base to a trihydrochloride.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06605620B1
Source datasetuspto-grants-2003_08
ORD IDord-dca9810a69b2445782004c58461b4e00
Source noteuspto-grants-2003_08